Role of serotonin in the regulation of the dynorphinergic system by a κ-opioid agonist and cocaine treatment in rat CNS

Neuroscience

Volumn 144, Issue 1, 2007, Pages 157-164

  D'Addario, C ^a   Di Benedetto, M ^a   Izenwasser, S ^b   Candeletti, S ^a   Romualdi, P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

cocaine; dynorphin; serotonin; U 69593

Indexed keywords

COCAINE; FLUOXETINE; KAPPA OPIATE RECEPTOR AGONIST; MESSENGER RNA; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; PRODYNORPHIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; COCAINE DEPENDENCE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; SENSITIZATION;

ANIMALS; BENZENEACETAMIDES; BLOTTING, NORTHERN; CENTRAL NERVOUS SYSTEM; COCAINE; DYNORPHINS; ENKEPHALINS; FLUOXETINE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NEOSTRIATUM; PROTEIN PRECURSORS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RNA PROBES; RNA, MESSENGER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 33751514482     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.09.008     Document Type: Article

References (69)

1. Adams D.H., Hanson G.R., and Keefe K.A. Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum. J Neurochem 75 (2000) 2061-2070
2. Basbaum A.I., Ralston D.D., and Ralston III H.J. Bulbospinal projections in the primates: A light and electromicrosopic study of a pain modulation system. J Comp Neurol 250 (1986) 311-323
3. Boja J.W., Mitchell W.M., Patel A., Kopajtic T.A., Carroll F.I., Lewin A.H., Abraham P., and Kuhar M.J. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12 (1992) 27-36
4. Carey R.J., DePalma G., Damianopoulos E., Shanahan A., Müller C.P., and Huston J.P. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res 1034 (2005) 162-171
5. Chalecka-Franaszek E., Chen H., and Chuang D.M. 5-Hydroxytryptamine2A receptor stimulation induces activator protein-1 and cyclic AMP-responsive element binding with cyclic AMP-responsive element-binding protein and Jun D as common components in cerebellar neurons. Neuroscience 88 (1999) 885-898
6. Chavkin C., James I.F., and Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215 (1982) 413-415
7. Chen H., Li H., and Chuang D.M. Role of second messengers in agonist up-regulation of 5-HT2A (5-HT2) receptor binding sites in cerebellar granule neurons: involvement of calcium influx and a calmodulin dependent pathway. J Pharmacol Exp Ther 275 (1995) 674-680
8. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
9. Civelli O., Douglass J., Goldstein A., and Herbert E. Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci U S A 82 (1985) 4291-4295
10. Collins S., D'Addario C., Romualdi P., Candeletti S., and Izenwasser S. Regulation of dynorphin gene expression by kappa-opioid agonist treatment. Neuroreport 13 (2002) 107-109
11. Collins S.L., D'Addario C., and Izenwasser S. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission. Eur J Pharmacol 426 (2001) 25-34
12. Collins S.L., Gerdes R.M., D'Addario C., and Izenwasser S. Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity. Behav Pharmacol 12 (2001) 237-245
13. Collins S.L., Kunko P.M., Ladenheim B., Cadet J.L., Carroll F.I., and Izenwasser S. Chronic cocaine increases kappa-opioid receptor density: lack of effect by selective dopamine uptake inhibitors. Synapse 45 (2002) 153-158
14. Cunningham K.A., Paris J.M., and Goeders N.E. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11 (1992) 112-123
15. Daunais J.B., Roberts D.C., and McGinty J.F. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport 4 (1993) 543-546
16. Di Benedetto M., D'Addario C., Collins S., Izenwasser S., Candeletti S., and Romualdi P. Role of serotonin on cocaine-mediated effects on prodynorphin gene expression in the rat brain. J Mol Neurosci 22 (2004) 213-222
17. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (1988) 5274-5278
18. Douglass J., McKinzie A.A., and Pollock K.M. Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol Endocrinol 8 (1994) 333-344
19. Fields H.L., and Basbaum A.I. Central nervous system mechanisms of pain modulation. In: Wall P.D., and Melzack P. (Eds). Textbook of pain. 3rd ed (1994), Churchill Livingstone, New York 243-257
20. Gunning P., Ponte P., Okayama H., Engel J., Blau H., and Kedes L. Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol 3 (1983) 787-795
21. Heidbreder C.A., Goldberg S.R., and Shippenberg T.S. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 616 (1993) 335-338
22. Herges S., and Taylor D.A. Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat. Eur J Pharmacol 374 (1999) 329-340
23. Ho B.Y., and Takemori A.E. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice. J Pharmacol Exp Ther 254 (1990) 8-12
24. Horner K.A., Adams D.H., Hanson G.R., and Keefe K.A. Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion. Neuroscience 131 (2005) 67-77
25. Hurd Y.L., and Herkenham M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res Mol Brain Res 16 (1992) 97-104
26. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2 (2001) 695-703
27. Izenwasser S., French D., Carroll F.I., and Kunko P.M. Continuous infusion of selective dopamine uptake inhibitors or cocaine produces time-dependent changes in rat locomotor activity. Behav Brain Res 99 (1999) 201-208
28. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev 72 (1992) 165-229
29. Kalyuzhny A.E., and Wessendorf M.W. Serotonergic and GABAergic neurons in the medial rostral ventral medulla express kappa-opioid receptor immunoreactivity. Neuroscience 90 (1999) 229-234
30. Kondo Y., Ogawa N., Asanuma M., Hirata H., Tanaka K., Kawada Y., and Mori A. Regional changes in neuropeptide levels after 5,7-dihydroxytryptamine-induced serotonin depletion in the rat brain. J Neural Transm Gen Sect 92 (1993) 151-157
31. Kreek M.J. Opiates, opioids and addiction. Mol Psychiatry 1 (1996) 232-254
32. Kwiat G.C., and Basbaum A.I. The origin of brainstem noradrenergic and serotoninergic projections to the spinal cord dorsal horn in the rat. Somatosens Mot Res 9 (1992) 157-173
33. Lucas J.J., Mellstrom B., Colado M.I., and Naranjo J.R. Molecular mechanisms of pain: serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons. Neuron 10 (1993) 599-611
34. Maniatis T., Fritsch E.F., and Sambrook J. Molecular cloning: a laboratory manual Vol. 1 (1982), Cold Spring Harbor, New York
35. Mathieu-Kia A.M., and Besson M.J. Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Brain Res Mol Brain Res 54 (1998) 141-151
36. Mello N.K., and Negus S.S. Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther 286 (1998) 812-824
37. Morris B.J., Reimer S., Hollt V., and Herz A. Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Brain Res 464 (1988) 15-22
38. Morrow B.A., and Roth R.H. Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system. Synapse 23 (1996) 174-181
39. Müller C.P., Carey R.J., De Souza Silva M.A., Jocham G., and Huston J.P. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse 45 (2002) 67-77
40. Müller C.P., Carey R.J., and Huston J.P. Serotonin as an important mediator of cocaine's behavioral effects. Drugs Today 39 (2003) 497-511
41. Müller C.P., Carey R.J., Salloum J.B., and Huston J.P. Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study. Neuropharmacology 44 (2003) 592-603
42. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 (2001) 119-128
43. Nestler E.J. Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25 (2004) 210-218
44. Oswald L.M., and Wand G.S. Opioids and alcoholism. Physiol Behav 81 (2004) 339-358
45. Pradhan S.N., Battacharyya A.K., and Pradhan S. Serotoninergic manipulation of the behavioral effects of cocaine in rats. Commun Psychopharmacol 2 (1978) 481-486
46. Richardson N.R., and Roberts D.C. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci 49 (1991) 833-840
47. Romualdi P., D'Addario C., Ferri S., Cox B.M., and Izenwasser S. Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine. Eur J Pharmacol 413 (2001) 207-212
48. Romualdi P., Donatini A., Izenwasser S., Cox B.M., and Ferri S. Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen. Brain Res Mol Brain Res 40 (1996) 153-156
49. Rosin A., Lindholm S., Franck J., and Georgieva J. Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neurosci Lett 275 (1999) 1-4
50. Sanders-Bush E., Bushing J.A., and Sulser F. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. J Pharmacol Exp Ther 192 (1975) 33-41
51. Schenk S., Partridge B., and Shippenberg T.S. U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology 144 (1999) 339-346
52. Schenk S., Partridge B., and Shippenberg T.S. Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology 151 (2000) 85-90
53. Sharma H.S., Nyberg F., and Olsson Y. Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique. Neurosci Res 14 (1992) 195-203
54. Shippenberg T.S., LeFevour A., and Heidbreder C. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J Pharmacol Exp Ther 276 (1996) 545-554
55. Spangler R., Unterwald E.M., and Kreek M.J. "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol Brain Res 19 (1993) 323-327
56. Spangler R., Zhou Y., Maggos C.E., Zlobin A., Ho A., and Kreek M.J. Dopamine antagonist and "binge" cocaine effects on rat opioid and dopamine transporter mRNAs. Neuroreport 7 (1996) 2196-2200
57. Steranka L.R., and Sanders-Bush E. Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism. J Pharmacol Exp Ther 206 (1978) 460-467
58. Tao R., and Auerbach S.B. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J Pharmacol Exp Ther 303 (2002) 549-556
59. Tran-Nguyen L.T., Baker D.A., Grote K.A., Solano J., and Neisewander J.L. Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology 146 (1999) 60-66
60. Turchan J., Lason W., Budziszewska B., and Przewlocka B. Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain. Neuropeptides 31 (1997) 24-28
61. Turchan J., Przewlocka B., Lason W., and Przewlocki R. Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience 85 (1998) 1051-1059
62. Turchan J., Przewlocka B., Toth G., Lason W., Borsodi A., and Przewlocki R. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 91 (1999) 971-977
63. Tzaferis J.A., and McGinty J.F. Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res Mol Brain Res 93 (2001) 27-35
64. Unterwald E.M. Regulation of opioid receptors by cocaine. Ann N Y Acad Sci 937 (2001) 74-92
65. Unterwald E.M., Rubenfeld J.M., and Kreek M.J. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 5 (1994) 1613-1616
66. Walsh S.L., and Cunningham K.A. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing, and subjective effects of cocaine. Psychopharmacology 130 (1997) 41-58
67. Wang Y.Y., Wu S.X., Liu X.Y., Wang W., and Li Y.Q. Effects of c-fos antisense oligodeoxynucleotide on 5-HT-induced upregulation of preprodynorphin, preproenkephalin, and glutamic acid decarboxylase mRNA expression in cultured rat spinal dorsal horn neurons. Biochem Biophys Res Commun 309 (2003) 631-636
68. - channel currents in rat sacral dorsal commissural neurons is mediated by protein kinases. Prog Physiol Sci 28 (1997) 233-236
69. Ziókowska B., Przewocka B., Mika J., Labuz D., and Przewocki R. Evidence for Fos involvement in the regulation of proenkephalin and prodynorphin gene expression in the rat hippocampus. Mol Brain Res 54 (1998) 243-251